Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001076
Abstract: Supplemental digital content is available in the text. Abstract Purpose/Background The Phase 3 program for RBP-7000, a once-monthly subcutaneous (SC) extended-release risperidone formulation approved for treatment of schizophrenia, consisted of a double-blind placebo-controlled trial (previously… read more here.
Keywords: rbp; rbp 7000; treatment; release risperidone ... See more keywords